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Abstract
The widespread chromosome instability observed in
tumors and in early stage carcinomas suggests that
aneuploidy could be a prerequisite for cellular trans-
formation and tumor initiation. Defects in tumor sup-
pressors and genes that are part of mitotic checkpoints
are likely candidates for the aneuploid phenotype. By
using flow cytometric, cytogenetic, and immunocyto-
chemistry techniques we investigated whether pRB
deficiency could drive perpetual aneuploidy in normal
human and mouse fibroblasts after mitotic checkpoint
challenge by microtubule-destabilizing drugs. Both
mouse and human pRB-deficient primary fibroblasts
resulted, upon release from a mitotic block, in prolife-
rating aneuploid cells possessing supernumerary cen-
trosomes. Aneuploid pRB-deficient cells show an
elevated variation in chromosome numbers among cells
of the same clone. In addition, these cells acquired the
capability to grow in an anchorage- independent way at
the same extent as tumor cells did suggesting aneu-
ploidy as an initial mutational step in cell transforma-
tion. Normal Mouse Embryonic Fibroblasts (MEFs)
harboring LoxP sites flanking exon 19 of the Rb gene
arrested in G2/M with duplicated centrosomes after
colcemid treatment. However, these cells escaped the
arrest and became aneuploid upon pRB ablation by CRE
recombinase, suggesting pRB as a major component of
a checkpoint that controls cellular ploidy.
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Introduction
Cancer cells are characterized not only by mutations in
specific oncogenes and tumor-suppressor genes, but they
also display gain and loss of chromosomes as well as
alterations in chromosome number (aneuploidy) [1–4].
Chromosomal instability (CIN) [2 ] could account for the
heterogeneity observed in individual tumors and could
underlie the clonal differences seen in the same solid tumor.
Recently, it has been suggested that CIN in cancer cells
could be associated with mutations in mitotic checkpoint
genes [5]. Near diploid tumor cells without the hSecurin
gene, a component of the complex of proteins responsible for
chromatid cohesion, became aneuploid over several ge-
nerations [6]. However, to date inactivation of hSecurin has
not been observed in human cancers suggesting that altered
expression of other genes must be responsible for the
aneuploidy observed in cancer. Also, it has been shown that
mammalian cells with reduced expression of MAD2 showCIN
even though additional mutations are likely necessary for
cellular transformation to occur readily [7,8].
An alternative view is that CIN is not generated by gene
mutation/s; instead it could result from an initial abnormal
chromosome complement within the cell [9 ]. This hypothesis
comes from studies that showed that treatments with non-
genotoxic drugs induce a near-complete aneuploidy [10].
Previously we showed that normal human fibroblasts
lacking functional pRB re- replicate their DNA when chal-
lenged with antimicrotubule drugs [11]. These cells probably
do not go through a ‘‘point of no return’’; instead they
decondense their chromosomes and return to a G2 phase
[12,13] from which they can re- replicate their DNA. Here we
show that transient polyploidization, by uncoupling DNA
replication and cytokinesis, can trigger CIN both in human
and murine pRB-deficient primary fibroblasts and that cells
derived following colcemid treatment are capable of unan-
chored growth in soft agar to the same extent as tumor cells.
By using mouse embryonic fibroblasts (MEFs) harboring
LoxP sites flanking exon 19 of the Rb gene [14], we
demonstrate a direct relationship between pRB ablation,
centrosome duplication, and generation of aneuploid cells.
Materials and Methods
Cell Culture
Normal human fibroblasts IMR90 (diploid human embryo-
nic lung fibroblasts, ATCC CCL-186), stably expressing a
neomycin resistance gene ( IMR90neo ), or neomycin resist-
ance and the gene encoding the human papillomavirus type
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16 (HPV16) E7 protein ( IMR90E7) were obtained by
retroviral gene transduction. Cells expressing E7 have
nonfunctional RB protein. MEFs with conditional Rb alleles
(RbLoxP / LoxP MEFs) were kindly provided by Dr. Marco
Crescenzi ( Istituto Superiore di Sanita`, Rome). RbLoxP / LoxP
MEFs were infected (MOI: 300, which ensures 90% to 95%
of successful infected fibroblasts) with the empty vector
J-pCA13 or with adenoviruses (AdCre) expressing the
Cre recombinase under control of the human cytomegalo-
virus (hCMV) immediate-early promoter to generate MEFs
devoid of pRB (Rb  /  MEFs). All adenoviruses used in
this study were replication-deficient (E1 region deleted).
Cells were cultured in DMEM supplemented with 10% FBS,
100 U/ml penicillin, and 0.1 mg/ml streptomycin (Euroclone,
Milan, Italy ).
Cell Cycle Analysis
Asynchronously growing cells were treated with 0.2 g/ml
colcemid (Demecolcine, Sigma) for 72 hours and then
released into complete medium without colcemid. DNA
content was determined using PI staining alone by treating
the cells with PBS containing 4 g/ml of PI and 40 g/ml
RNase. BrdU incorporation (10 M for 4 hours) was used to
determine DNA synthesis of the cells released in medium
without colcemid. Analysis of BrdU- labeled cells was
conducted as described previously [15] and samples were
analyzed on a Becton Dickinson (NJ, USA) FACScan.
Experiments were repeated twice; 5000 events were
analyzed for each sample, and representative experiments
are shown.
Fluorescence In Situ Hybridization
Centromeric probes specific for chromosome 2 and 6
(kindly provided by Dr. Mariano Rocchi, University of Bari,
Italy) were used for interphase and metaphase fluores-
cence in situ hybridization (FISH). FISH was done following
published procedures [15] with minor modifications. Briefly,
after RNase and proteinase K treatment and DNA denatu-
ration in 70% formamide/2 SSC, cells were dehydrated in
an ethanol series. Following overnight incubation at 378C
in a hybridization mixture consisting of 50% deionized
formamide, 5% dextrane sulfate, 2 SSC, 1% Tween 20,
100 g/ml salmon sperm DNA, and 100 ng biotinylated and
digoxigenated pX2 (chr. 2) and pEDZ6 (chr. 6) probes, the
slides were washed and blocked in 4 SSC/0.5% nonfat
dry milk. Slides were layered with FITC-conjugated avidin
or antidigoxigenin rhodamine (Roche Molecular, Mannheim,
Germany) in 4 SSC/0.5% blocking reagent. Slides were
stained with Hoechst 33258 (0.05 g/ml), examined on a
Zeiss (Gottingen, Germany) Axioskop microscope equipped
for fluorescence, and the observed nuclei and metaphases
were captured on a CCD camera (Zeiss). Images were
transferred to Adobe PhotoShop for printing.
Determination of Ploidy
Asynchronous cells were treated with 0.2 g/ml colcemid
(Demecolcine, Sigma) for 4 hours. Cells were harvested by
trypsinization, swollen in 75 mM KCl at 378C, fixed with 3:1
methanol:acetic acid (v:v), and dropped onto clean, ice-cold
glass microscope slides. The slides were air dried and
stained with 3% Giemsa in phosphate-buffered saline for
10 minutes. Chromosome numbers were evaluated using a
Zeiss Axioskop microscope under a 100 objective.
Immunofluorescence Microscopy
To visualize multipolar spindles, cells grown on rounded
glass coverslips were treated with Taxol (Paclitaxel,
Sigma) 1 g/ml for 2 hours and then fixed with 3.7%
formaldehyde for 10 minutes at 378C, permeabilized with
0.1% Triton X (Sigma) in PBS for 15 minutes, and blocked
with 0.1% BSA for 30 minutes, both at room temperature.
Coverslips were incubated with a mouse monoclonal anti-
body against  - tubulin (Sigma; diluted 1:200 in PBS)
overnight at 48C, followed by a goat anti -mouse IgG-FITC
conjugated secondary antibody (Sigma; diluted 1:100 in
PBS) for 1 hour at 378C. For immunostaining of centrosomes
of asynchronously grown cells, we used a mouse mono-
clonal antibody against  - tubulin (Sigma; diluted 1:4000 in
PBS) incubated overnight at 48C. Cells were washed in PBS
buffer and exposed to a FITC-conjugated goat anti -mouse
IgG secondary antibody (Sigma; diluted 1:100 in PBS) for
1 hour at 378C. Nuclei were visualized with Hoechst 33258
(0.05 g/ml) and examined on a Zeiss Axioskop microscope
equipped for fluorescence and images were captured with a
CCD digital camera (Zeiss). Images were transferred to
Adobe PhotoShop for printing.
Immunoblot Analyses
For immunoblot analyses, MEFs were lysed in SDS/
PAGE sample buffer, protein extracts were resuspended in
loading buffer (0.125 M Tris–HCl, 4% SDS, 20% v/v
glycerol, 0.2 M dithiothreitol, 0.02% bromphenol blue, pH
6.8), and 60 g of protein (as determined by the Bradford
assay) was loaded per lane on a 6% SDS PAGE gel. After
gel electrophoresis proteins were electrotransferred onto a
Hybond Cmembrane (Amersham Life Science, Milan, Italy ).
Electroblotted gel was stained with Coomassie blue and the
membrane was reversibly stained with Ponceau S to verify
equal loading and transfer. The membrane was blocked in
5% (w/v) nonfat milk in TBST buffer (10 mM Tris pH 8.0,
150 mM NaCl, 0.1% Tween 20) at room temperature and
incubated overnight at 48C with the anti -pRB primary
antibody (C-15, Santa Cruz Biotechnology, Santa Cruz,
CA) 1 g/ml in blocking solution. After three washes with
TBST buffer, the blot was incubated in horseradish
peroxidase-conjugated anti -goat IgG (Santa Cruz Biotech-
nology, diluted 1:5000) for 1 hour at room temperature and
washed again three times with TBST buffer. Blot was
developed with chemiluminescent reagents (SuperSignalW-
est Pico, Pierce Rockford, IL) and exposed to CL-Xposure
film (Pierce, Rockford, IL) for 1 to 5 minutes.
Focus Assay
We have used a base layer (2 ml) composed of DMEM,
20% FBS, and 1% Noble agar. Noble agar was allowed to sit
in six-well multidish plates of 35-mm diameter ( Iwaki, Bibby
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Sterlin Staffordshire, England, UK). This substrate was
overlaid with 2 ml of a second layer of agar media (0.3%
DMEM, 20% FBS) containing a suspension of 10,000 cells /
dish and incubated at 378C in a 5% CO2 atmosphere. Foci
were visible within 10 to 14 days.
Results
pRB-Deficient Human Fibroblasts Become Aneuploid
upon Release from Colcemid and Show Potential for
Transformation
Previously, we showed that pRB deficiency in human and
mouse fibroblasts leads to increased ploidy in the presence
of spindle inhibitors due to re- replication of most, if not all,
of the genome without inducing DNA damage [11]. This
initial abnormal chromosome complement could be the
basis for generating CIN in human cells when associated
with malfunction of a checkpoint controlling the correct
ploidy or reduplicated centrosomes. To further examine this
hypothesis, both normal ( IMR90neo) and pRB-deficient
( IMR90E7) human fibroblasts were treated with the anti-
microtubule drug colcemid for 72 hours to induce transient
polyploidization. The DNA content and distribution in E7-
expressing cells showed, by FACScan analyses, that the
majority of the cells accumulated with a 4 N (70%) and 8 N
DNA content (12%) (Figure 1A ). In contrast, there were no
IMR90neo cells with an 8 N DNA content, and 36% of cells
accumulated with a 4 N DNA content. Bivariate FACScan
analyses (BrdU vs propidium iodide [PI ] incorporation) of
IMR90E7 cells colcemid treated for 72 hours and then
released for 4 hours in complete medium without colcemid,
showed that additional 12% of IMR90E7 cells (Figure 1B )
were able to enter S phase with respect to those analyzed at
72 hours. The cell cycle profiles showed that these additional
cells in S-phase (BrdU positive) originated from the cells
with a 4 N DNA content that re- replicated their DNA (data
not shown). On the contrary, IMR90neo cells treated and
released in the same way did not show any BrdU
incorporation at the indicated times.
We next asked whether these treated cells (henceforth
designated IMR90neo- t and IMR90E7- t ) were capable of
further growth when released into complete medium without
the drug. During the first week after the release, we estimated
that about 40% of IMR90E7- t cells died. However, in the
second week of culture the remaining cells proliferated at
the same rate as IMR90E7 cells (parental ) when cultured in
the absence of the mitotic inhibitor. In contrast, IMR90neo- t
cells proliferated very slowly, becoming completely arrested
within 2 weeks following the release. We did chromosome
counts on 100 metaphase spreads of these IMR90E7- t cells
to ascertain the ploidy status. Cytogenetic analysis showed
more than 90% of the cells were aneuploid (Figure 1D ) and
contained different numbers of chromosomes permetaphase
(range of chromosomes per metaphase 47 to 80). In
contrast, all IMR90E7 and IMR90neo cells examined were
diploid. Fluorescence in situ hybridization (FISH) with
chromosome-specific anti -centromeric probes, both on
metaphases and nuclei, confirmed differences in chromo-
some numbers between untreated and treated E7-express-
ing cells (Figure 1C ). We isolated several single-cell clones
from the population of colcemid-released IMR90E7- t cells
from two independent experiments, to determine ploidy in
pRB-deficient cells in which DNA replication is uncoupled
from cytokinesis. Clones were allowed to expand, and after 1
week of growth FACScan analyses showed that the DNA
content for all of them was greater than that of the parental
cells, indicating that these cells had acquired a perpetual
aneuploidy (Figure 2A ). Alteration of ploidy in these cells was
confirmed by determining chromosome numbers (Figure
2B ). Cytogenetic analyses of pRB-deficient cells released
from the colcemid block and analyses of single-cell clones
showed high variability in chromosome numbers from cell to
cell suggesting random occurrence of chromosomal gain and
loss. These observations were consistently confirmed during
at least 3 months of cell culture. The observed heterogeneity
in chromosome numbers in these pRB-deficient cells
suggests that the initial trigger ( transient polyploidy) results
in chromosomal instability that allows aneuploidy cells to
proliferate and perpetuate.
Aneuploidy in tumors has been associated with the
presence of multipolar mitotic spindles strictly correlated
with alterations in centrosome numbers. We examined the
spindle organization in these growing aneuploid cells by  -
tubulin staining (Figure 2C ) and found multipolar spindles in
all of the cells scored. Chromosomal instability (CIN) is a
hallmark of cancer and accounts for the heterogeneity
observed in tumor cells. However, the possibility that the
acquired aneuploidy is an initial event in the transformation
process is still debated. Therefore, we characterized the
aneuploid IMR90E7- t population and the independently
derived aneuploid cell clones for their potential for trans-
formation. Both the IMR90E7- t population and cell clones
grew in soft agar as discrete colonies indicating the capability
of these cells to grow in an anchorage- independent manner.
Estimation of the number of foci (Figure 2D ) revealed that
these cells have a potential for transformation comparable to
that displayed from the tumor cells DLD1 used as a positive
control. In contrast, wild - type IMR90neo and IMR90E7 cells
failed to grow in soft agar (Figure 2D ).
pRB Ablation Allows Growth of MEFs Arrested with
Duplicated Centrosomes
It has been shown that centrosome duplication requires
both E2F and CDK2/cyclin A in Chinese hamster ovary cells
[16], and that stable expression of HPV16-E7 oncoprotein in
keratinocytes, but not in fibroblasts [17], causes induction of
numerical centrosome abnormalities that could represent an
early event during neoplastic progression potentially driving
genomic destabilization [18]. However, HPV16-E7 onco-
protein causes inactivation of other cellular targets such as
p107 and p130 pRB’s family protein, p21WAF1 -Cip1 [19] and
insulin- like growth factor binding protein 3 ( IGFBP-3) [20].
Then, we determined whether the lack of pRB only is
sufficient for allowing perpetual aneuploidy associated with
centrosome reduplication in mammalian cells.
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To this aim we used MEFs carrying conditional Rb
alleles (RbLoxP /LoxP MEFs) in which two LoxP sites are
inserted into the introns surrounding exon 19 of the Rb
gene [14]. We infected RbLoxP /LoxP MEFs with adenovi-
ruses expressing the Cre recombinase (AdCre) to excise
the exon 19 and to generate cells with truncated pRB
(Rb  /  MEFs), which are functionally equivalent to Rb
null cells. RbLoxP /LoxP MEFs were also infected with
adenoviruses that did not express the Cre transgene to
generate isogenic murine cells (pRB proficient, indicated
as RbLoxP /LoxP ) to be used as a control. Western blot
experiments (Figure 3A ) showed that as early as 96 hours
RbLoxP /LoxP MEFs infected with AdCre were completely
devoid of pRB when compared to the same cells infected
with adenoviruses that did not express the Cre transgene.
Infected cells were allowed to expand and 2 weeks after
Figure 1. Effects of mitotic arrest on DNA replication and ploidy in IMR90neo and IMR90E7 human cells. (A ) FACS profiles of PI - stained IMR90neo and IMR90E7
cells untreated or treated with colcemid ( 0.2 g /ml ). (B ) Histograms summarizing cell cycle analyses of asynchronous IMR90neo and IMR90E7 colcemid treated
and released into medium without colcemid. (C ) Detection of aneuploidy in IMR90E7 cells using centromeric probes to human chromosome 2 (green ) and 6 ( red ).
1 and 2: IMR90E7; 3 and 4: IMR90E7 treated for 72 hours with colcemid and released into medium without colcemid. (D ) Chromosome /metaphase numbers in
IMR90E7 cells treated for 72 hours with colcemid and released for 2 weeks.
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they were colcemid treated. We determined by FACScan
analysis the DNA content of both RbLoxP /LoxP and Rb  / 
MEFs after exposure to colcemid. Figure 3B shows typical
flow cytometry results at 0 and 72 hours. Colcemid- treated
( time 72 hours) RbLoxP /LoxP MEFs showed increase in 4 N
cells but not in 8 N cells when compared to untreated ( time
0 hours) RbLoxP /LoxP MEFs that showed the majority of
the cells with a 2 N DNA content. As expected PI analyses
revealed that untreated Rb  /  MEFs were predominantly
2 N or 4 N with very few >4 N cells. In contrast the majority
of Rb  /  MEFs treated with colcemid accumulated with a
4 N and >4 N of DNA content. Additional cytogenetic
analyses showed that more than 50% of these colcemid-
treated Rb  /  MEFs were polyploid (Figure 3C ). Evalua-
tion of centrosome numbers, by  - tubulin detection, in these
colcemid- treated Rb  /  MEFs revealed that 42% of cells
had more than two centrosomes, 46% had two centrosomes,
and only 12% had one centrosome. This indicates that DNA
Figure 2. Cell cycle analyses and features of IMR90E7 - t derived clones. (A ) FACS profiles of asynchronous PI - stained IMR90E7 and IMR90E7 - t derived clones
showing the presence of hyperdiploidy in all the clones isolated. (B ) Chromosome /metaphase numbers in IMR90E7 - t derived clones displaying the presence of
aneuploid metaphases. (C ) Presence of multipolar spindles in the clone A. The spindle was visualized by Immunofluorescence staining for  - tubulin, and nuclei
were visualized by Hoechst 33258. ( 1 ) Control metaphase ( IMR90E7 ); ( 2 ) metaphases of clone A displaying asymmetrical distribution of the condensed
chromosomes. (D ) Numbers of foci scored after 2 weeks growth in 0.3% agar supplemented DMEM for IMR90E7 - t cells and the derived clones: A–B–C–D; DLD1:
colon cancer cells used as a positive control.
Figure 3. Effect of mitotic arrest on DNA replication and ploidy in RbloxP / loxP and Rb /  MEFs. (A ) Western blot analysis showing the level of pRB expression after
96 hours from the adenoviral infection: ( lane 1 ): pRbloxP / loxP MEF infected with the empty vector and ( lane 2 ) with the adenovirus expressing the Cre recombinase.
Equal loading of proteins on the blot was evaluated by Ponceau S staining, Western blot was probed with a monoclonal anti pRB antibody raised against the carboxy
terminus of the RB protein. (B ) Cellular ploidy as revealed by FACS profiles of PI - stained RbloxP / loxP and Rb /  MEFs untreated or treated with colcemid
(0.2 g /ml ). (C ) Metaphase analysis showing the presence of aneuploid metaphase spreads in Rb / MEF- t at 2 weeks from the release. (D ) Visualization of the
spindle poles by  - tubulin staining in untreated Rb /  MEFs and in Rb / MEF- t released for 2 weeks. (E ) Bivariate FACS profiles (BrdU vs PI ) of RbloxP / loxP
and Rb /  MEFs untreated, treated with colcemid (72 hours ) and released for 2 weeks, and of RbloxP / loxP MEFs released from colcemid arrest and infected with
AdCre. These last cells were analyzed after 144 hours from infection. ( F ) Centrosome amplification in MEFs released from the colcemid block detected after staining
with an antibody directed against  - tubulin. Top and bottom panels refer to different microscopy fields of the same cell type. Control Rb loxP / loxP MEFs - t ( 1 ) released
from colcemid, show one or two centrosomes; the same result was observed in untreated Rb /  MEFs (3 ). Variation in centrosome numbers was observed in
RbloxP / loxP MEF - t+AdCre ( 2 ) and in Rb / MEF - t ( 4 ).
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re- replication, because of lack of pRB, is accompanied by
centrosome reduplication.
Then, we examined the fate of the treated cells by
releasing both RbLoxP /LoxP and Rb  /  MEFs (henceforth
indicated as RbLoxP /LoxP MEFs- t and Rb  /  MEFs- t )
from the colcemid block. We observed that RbLoxP /LoxP
MEFs- t remained arrested for at least 2 weeks. In contrast,
Rb  /  MEFs- t proliferated as did IMR90E7- t cells
Neoplasia . Vol. 4, No. 5, 2002
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(Figure 3E ). Cytogenetic analyses performed 4 weeks after
the release from the block imposed by colcemid showed that
the great majority of the Rb  /  MEFs- t were aneuploid
(75%) suggesting that lack of pRB allowed aneuploid cells to
proliferate. The staining of these cells for  - tubulin revealed
the presence of high numbers of tripolar and multipolar
spindles (Figure 3D ). To examine whether RbLoxP /LoxP
MEFs- t cells, which experienced a prolonged if not
permanent arrest upon colcemid treatment, were able to
escape the arrest following pRB ablation, they were infected
with the adenovirus AdCre to excise by recombination exon
19 of the Rb gene and thus inactivate it. These cells
( indicated as RbLoxP /LoxP MEFs- t+AdCre) escaped the
arrest and started to proliferate similarly to Rb  /  MEFs- t
(Figure 3E ). Cytogenetic analyses revealed that more than
50% of these cells become aneuploid. In addition, centro-
some analysis (Figure 3F , Table 1), at 1 week after the
infection, by  - tubulin staining of RbLoxP /LoxP MEFs-
t+AdCre cells showed an increase in cells harboring two
centrosomes (55%) and more than two centrosomes (20%,
range 3 to 8), and only 25% of the cells with one centrosome.
On the contrary, RbLoxP /LoxP MEFs- t cells showed that 58%
and 37% of the cells had one or two centrosomes,
respectively, as expected whether treated cells are arrested
in G1 and G2/M, and only 5% of RbLoxP /LoxP MEFs- t cells
hadmore than two centrosomes. Both untreatedRbLoxP /LoxP
and Rb  /  MEFs showed a similar percentage of cells with
one or two centrosomes. The increasing number of cells
harboring supernumerary centrosomes in RbLoxP /LoxP
MEFs- t+AdCre suggests that pRB ablation allow cells
arrested with at least two centrosomes and with altered
ploidy to escape the arrest.
Discussion
A current paradigm in cancer research states that cancer
originates from a single founder cell in which mutations in few
crucial genes have occurred. However, this paradigm does
not seem to be in accordance with either epidemiological
data or with multiple mutations and chromosomal aberra-
tions, both structural and numerical, which are found in the
majority of tumors. These chromosomal alterations are
believed to destabilize the genome and further increase the
occurrence of new changes [9]. Aneuploidy observed in the
majority of tumors and in early stage carcinomas strongly
suggests that it could be considered a prerequisite in
initiation as well as in tumor progression [2,3 ]. The
occurrence of transient polyploidization caused by DNA re-
replication [11] could be considered a trigger for generating
CIN and perpetual aneuploidy in human cells [10]. Our
findings both in human and murine cells suggest that pRB
could be a major component of a pathway that controls ploidy
when the mitotic checkpoint is activated by antimicrotubule
drugs. Our results, showing that pRB-deficient cells are able
to tolerate aneuploidy and in turn acquire the ability to grow in
an anchorage- independent way, support the hypothesis that
aneuploidy may be a driving force in tumorigenesis rather
than a side effect of the transformation process driven by
mutations in oncogenes and tumor-suppressor genes [21].
Although changes in chromosome numbers might be caused
by alterations in specific genes of the mitotic checkpoint
[6,8,22], our results suggest that also pRB is playing an
important role in this process. In fact, when the mitotic
checkpoint is challenged, pRB deficiency predisposes cells
to aneuploidy by DNA re-replication [11], and the concom-
itant centrosome reduplication is necessary to maintain and
perpetuate the resulting aneuploid cells. In addition, these
findings suggest that lack of pRB is necessary to allow
aneuploid cells to proliferate despite the presence of super-
numerary centrosomes, which are thought to cause mitotic
failure, producing nonviable daughter cells [23]. Mammalian
cells that do not have mitotic checkpoints defects, when
exposed to spindle inhibitors for a long time, eventually adapt
and exit mitosis, escaping the inhibitor - induced arrest.
Recently, it has been shown that p53 competent cells
exposed to antimicrotubule drugs, after adaptation, arrest
in a G1- like cell cycle phase [24]. Surprisingly, p53-
deficient human fibroblasts (expressing the HPV-16
E6-oncoprotein) that showed polyploidy after 72 hours of
colcemid exposure, arrested with the subsequent passages
in culture when released in medium without colcemid
(L.L. and A.D.L., unpublished observations). These findings
suggest the existence of a pathway dependent on pRB,
likely activated in normal diploid fibroblast adapted cells,
which is able to monitor alterations in cellular ploidy or
centrosome duplication, thereby inducing a prolonged cell
cycle arrest.
Many reports have suggested the existence of a relation-
ship between reduplicated centrosomes and the presence of
gross aneuploidy. However, it is still debated whether
centrosome alterations are a cause of genomic instability
or a consequence of alterations in the cell cycle of cancer
cells [25]. The ability of both HPV-16 E7 oncoprotein and
E2F together with CDK2/cyclin A to induce centrosome
duplication in mammalian cells [16,17] suggests that
abrogation of pRB functions may have similar effects on
centrosome homeostasis that could drive subsequent
aneuploidy in tumor cells. Our findings that in proliferating
human fibroblasts lack of pRB, caused by HPV16-E7
oncoprotein expression, did not affect centrosome number
differently from that previously observed in keratinocytes
[17] likely reflects differences in cell types used. This
suggests that pRB dysfunction does not have any appa-
rent deleterious effect on centrosomes in asynchronously
Table 1. Centrosome Analysis in Mouse Embryonic Fibroblasts.
Cells % 1
centrosome
% 2
centrosomes
% >2
centrosomes
Rb LoxP / LoxP MEF 80 20 –
Rb LoxP / LoxP MEF - t 58 37 5
Rb LoxP / LoxP MEF - t+AdCre 25 55 20
Rb  / MEF 79 21 –
Rb  / MEF- t 20 64 16
t: cells treated with colcemid for 72 hours and then released for 2 weeks.
t+AdCre: cells treated with colcemid for 72 hours released for 2 weeks and
then infected with the adenovirus AdCre.
386 Chromosome Instability (CIN) in pRB-deficient Cells Lentini et al.
Neoplasia . Vol. 4, No. 5, 2002
growing fibroblasts. However, our results that RbLoxP /LoxP
MEFs- t arrested for 2 weeks with a 4 N DNA content and
duplicated centrosomes were able to escape the arrest only
after pRB ablation, suggest the existence of a checkpoint, in
which pRB plays a central role, which monitors centrosome
numbers and when activated arrests cells in a G1- like cell
cycle phase.
Finally, our results support the following scenario in
mammalian cells. Duplicated centrosomes reduplicate in
mitotic arrested cells whether a new round of DNA synthesis
occurs because of pRB dysfunction. When the mitotic block
is over, the checkpoint is activated by the presence of
supernumerary centrosomes and the signal transmitted to
pRB, which halts further cell cycle progression. On the
contrary pRB-deficient cells could progress in the cell cycle
and undergo cytokinesis with more than one centrosome
inherited by each daughter cell. Then, some of the aneuploid
pRB-deficient cells are capable to proliferate and perpetuate
both the CIN phenotype and centrosome hypertrophy.
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